IN8BIO, INC. Construction in Progress, Gross
IN8BIO, INC. (INAB) had Construction in Progress, Gross of $0 as of 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:ConstructionInProgressGross · last filed 2025-03-13
- 2024-12-31: Construction in Progress, Gross $0.00.
- 2024-09-30: Construction in Progress, Gross $0.00.
- 2024-06-30: Construction in Progress, Gross $265.00K.
- 2024-03-31: Construction in Progress, Gross $203.00K.
| Period end | Construction in Progress, Gross | Construction in Progress, Gross as first filed |
|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-13 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $265.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $203.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $182.00K 10-K · filed 2025-03-13 | |
| 2023-09-30 | $145.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $93.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $182.00K 10-Q · filed 2024-05-09 | $45.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $29.00K 10-K · filed 2024-03-14 | |
| 2022-09-30 | $3.20M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.41M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $497.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $403.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $183.00K 10-Q · filed 2021-11-10 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |